High prevalence of B-RAF mutation in papillary carcinoma of the thyroid in North-East Italy

International Journal of Surgical Pathology

Volumn 18, Issue 3, 2010, Pages 173-176

  Girlando, Salvatore ^a   Cuorvo, Lucia Veronica ^a   Bonzanini, Mariella ^a   Morelli, Luca ^a   Amadori, Pierluigi ^b   Dalla Palma, Paolo ^a   Barbareschi, Mattia ^a  

^a SANTA CHIARA HOSPITAL   (Italy)

^b Azienda Provinciale per i Servizi Sanitari   (Italy)

Author keywords

B RAF; Fine needle aspiration cytology; Molecular pathology; Mutational analysis; Papillary carcinoma of the thyroid

Indexed keywords

B RAF KINASE; GLUTAMIC ACID; VALINE;

ARTICLE; ASPIRATION BIOPSY; ASPIRATION CYTOLOGY; CANCER CLASSIFICATION; CONTROLLED STUDY; DIAGNOSTIC VALUE; GENE MUTATION; GENETIC ASSOCIATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; ITALY; MUTATIONAL ANALYSIS; PHENOTYPE; PRIORITY JOURNAL; THYROID PAPILLARY CARCINOMA; TUMOR BIOPSY;

BIOPSY, FINE-NEEDLE; CARCINOMA, PAPILLARY; CARCINOMA, PAPILLARY, FOLLICULAR; DNA MUTATIONAL ANALYSIS; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; ITALY; MUTATION; PROTO-ONCOGENE PROTEINS B-RAF; THYROID NEOPLASMS; THYROIDECTOMY; TUMOR MARKERS, BIOLOGICAL;

EID: 77952284460     PISSN: 10668969     EISSN: 19402465     Source Type: Journal    
DOI: 10.1177/1066896910363133     Document Type: Article

References (24)

1. Santoro M., Carlomagno F., Hay ID, et al. Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype. J Clin Invest. 1992 ; 89: 1517-1522.
2. Bongarzone I., Vigneri P., Mariani L., Collini P., Pilotti S., Pierotti MA RET/NTRK1 rearrangements in thyroid gland tumors of the papillary carcinoma family: correlation with clinicopathological features. Clin Cancer Res. 1998 ; 4: 223-228.
3. Cohen Y., Rosenbaum E., Clark DP, et al. Mutational analysis of BRAF in fine needle aspiration biopsies of the thyroid: a potential application for the preoperative assessment of thyroid nodules. Clin Cancer Res. 2004 ; 10: 2761-2765.
4. Namba H., Nakashima M., Hayashi T., et al. Clinical implication of hot spot BRAF mutation, V599E, in papillary thyroid cancers. J Clin Endocrinol Metab. 2003 ; 88: 4393-4397.
5. Nikiforova MN, Kimura ET, Gandhi M., et al. BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas. J Clin Endocrinol Metab. 2003 ; 88: 5399-5404.
6. Soares P., Trovisco V., Rocha AS, et al. BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC. Oncogene. 2003 ; 22: 4578-4580.
7. Hayashida N., Namba H., Kumagai A., et al. A rapid and simple detection method for the BRAF(T1796A) mutation in fine-needle aspirated thyroid carcinoma cells. Thyroid. 2004 ; 14: 910-915.
8. Chiosea S., Nikiforova M., Zuo H., et al. A novel complex BRAF mutation detected in a solid variant of papillary thyroid carcinoma. Endocr Pathol. 2009 ; 20: 122-126.
9. De FV, Giannini R., Tamburrino A., et al. Functional characterization of the novel T599I-VKSRdel BRAF mutation in a follicular variant papillary thyroid carcinoma. J Clin Endocrinol Metab. 2008 ; 93: 4398-4402.
10. Troncone G., Cozzolino I., Fedele M., Malapelle U., Palombini L. Preparation of thyroid FNA material for routine cytology and BRAF testing: A validation study [published online ahead of print August 19, 2009]. Diagn Cytopathol. 2009 Aug 19; 38 (3). 172-176.
11. Xing M. BRAF mutation in papillary thyroid microcarcinoma: the promise of better risk management. Ann Surg Oncol. 2009 ; 16: 801-803.
12. Moon HJ, Kwak JY, Kim EK, et al. The role of BRAF(V600E) mutation and ultrasonography for the surgical management of a thyroid nodule suspicious for papillary thyroid carcinoma on cytology [published online ahead of print July 31, 2009]. Ann Surg Oncol. 2009 Nov; 16 (11). 3125-3131.
13. Nikiforova MN, Nikiforov YE Molecular genetics of thyroid cancer: implications for diagnosis, treatment and prognosis. Expert Rev Mol Diagn. 2008 ; 8: 83-95.
14. Lee JH, Lee ES, Kim YS Clinicopathologic significance of BRAF V600E mutation in papillary carcinomas of the thyroid: a meta-analysis. Cancer. 2007 ; 110: 38-46.
15. Chung KW, Yang SK, Lee GK, et al. Detection of BRAFV600E mutation on fine needle aspiration specimens of thyroid nodule refines cyto-pathology diagnosis, especially in BRAF600E mutation-prevalent area. Clin Endocrinol (Oxf). 2006 ; 65: 660-666.
16. Nikiforov YE Thyroid carcinoma: molecular pathways and therapeutic targets. Mod Pathol. 2008 ; 21 (suppl 2). S37 - S43.
17. Zatelli MC, Trasforini G., Leoni S., et al. BRAF V600E mutation analysis increases diagnostic accuracy for papillary thyroid carcinoma in fine-needle aspiration biopsies. Eur J Endocrinol. 2009 ; 161: 467-473.
18. Rowe LR, Bentz BG, Bentz JS Detection of BRAF V600E activating mutation in papillary thyroid carcinoma using PCR with allele-specific fluorescent probe melting curve analysis. J Clin Pathol. 2007 ; 60: 1211-1215.
19. Frattini M., Ferrario C., Bressan P., et al. Alternative mutations of BRAF, RET and NTRK1 are associated with similar but distinct gene expression patterns in papillary thyroid cancer. Oncogene. 2004 ; 23: 7436-7440.
20. Salvatore G., Giannini R., Faviana P., et al. Analysis of BRAF point mutation and RET/PTC rearrangement refines the fine-needle aspiration diagnosis of papillary thyroid carcinoma. J Clin Endocrinol Metab. 2004 ; 89: 5175-5180.
21. Carta C., Moretti S., Passeri L., et al. Genotyping of an Italian papillary thyroid carcinoma cohort revealed high prevalence of BRAF mutations, absence of RAS mutations and allowed the detection of a new mutation of BRAF oncoprotein (BRAF(V599lns)). Clin Endocrinol (Oxf). 2006 ; 64: 105-109.
22. Fugazzola L., Puxeddu E., Avenia N., et al. Correlation between B-RAFV600E mutation and clinico-pathologic parameters in papillary thyroid carcinoma: data from a multicentric Italian study and review of the literature. Endocr Relat Cancer. 2006 ; 13: 455-464.
23. Sapio MR, Posca D., Raggioli A., et al. Detection of RET/ PTC, TRK and BRAF mutations in preoperative diagnosis of thyroid nodules with indeterminate cytological findings. Clin Endocrinol (Oxf). 2007 ; 66: 678-683.
24. Frasca F., Nucera C., Pellegriti G., et al. BRAF(V600E) mutation and the biology of papillary thyroid cancer. Endocr Relat Cancer. 2008 ; 15: 191-205.